DRD2 and hyperprolactinemia: All FDA-approvedantipsychotics are D2R partial agonists or antagonists.In addition, D2R ligands are used in the treatment of restlesslegs syndrome, postoperative nausea and vomiting, hyperprolactinemia,and Tourette’s syndrome.